M&A strategy and process shifts | M&A Summit

By William Jefferson Black

Throughout the Intralinks Virtual M&A Summit there was a consensus that the functioning of the financial markets makes this period different from the 2008-2009 economic decline.

Nonetheless, dealmakers are strained to evaluate M&A as the highest and best use of capital, if valuation declines make this an opportune time to approach targets, and whether to continue inflight deals.

A recommendation, that was echoed by many of the participants, was to consider more structured tools for...

Read more

Transaction insurance now being used for asset sales under Bankruptcy Code section 363

By Mr. Bryan M. O'Keefe & Mr. James B. Sowka

Purchasing assets from an insolvent entity on a truncated timeline with limited due diligence and no indemnities is not a process for the financial faint of heart. 

The use of reps and warranties insurance in bankruptcy sales may help both debtors and asset purchasers, according to a new paper from Seyfarth Shaw. 

Transactions that are executed under Bankruptcy Code section 363 can provide a higher value for debtors while simultaneously providing...

Read more

Study on M&A value creation shows high level of divestiture activity

By Mr. Les Baird & Mr. David Harding & Mr. Andrei Vorobyov & Ms. Shikha Dhar

Divestitures represented almost two-thirds of strategic deals, by value, during the past decade.

The authors of this study, from the consulting firm Bain & Co., look at divestitures as opportunities to release, “the time, talent and energy tied up in nonstrategic businesses”.  They also point to the freeing of capital for higher growth pursuits as they study companies that use divestitures more often.

Their research on M&A value creation over the past two decades shows that...

Read more

Modifications to merger review procedures may cause significant delays

Modifications to merger review procedures may cause significant delays
By Mr. Bill Batchelor & Mr. Andrew L. Foster & Mr. Kenneth B. Schwartz & Mr. David P. Wales

The global spread of the coronavirus has disrupted merger review procedures, as the authors of this paper explain. Dealmakers should expect delays in the antitrust review of notified transactions and material extension of prenotification reviews, with some non-U.S. agencies refusing to accept formal notifications.

Only a limited number of countries’ competition authorities have fully suspended activities, closed or announced an automatic suspension of review deadlines; additional suspensions are likely as the...

Read more